Skip to main content

Canadian drug companies join forces to produce monkeypox vaccine

Share

Montreal-based biopharmaceutical company PnuVax and Ontario-based drug manufacturer Biolyse Pharma announced Wednesday that they have signed an agreement to mass produce a monkeypox vaccine.

The two companies say they have the capabilities to produce millions of doses nationwide.

The undertaking could add up to 50 employees per company.

Monkeypox is a highly contagious disease that can cause painful lesions.

About 1,000 cases have been reported in Canada to date.

-- This report by The Canadian Press was first published in French on Aug. 10, 2022. 

CTVNews.ca Top Stories

Barron Trump declines to serve as an RNC delegate

Former U.S. President Donald Trump's youngest son, Barron Trump, has declined to serve as a delegate at this summer’s Republican National Convention, according to a senior Trump campaign adviser and a statement from Melania Trump's office.

Stay Connected